Role of Nanotechnology in Pharmaceutical Product Development
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 96 (10), 2547-2565
- https://doi.org/10.1002/jps.20875
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Prolonged blood concentration of prednisolone after intravenous injection of liposomal palmitoyl prednisoloneJournal of Controlled Release, 2006
- Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micellesJournal of Controlled Release, 2005
- Transdermal delivery of mixnoxidil with block copolymer nanoparticlesJournal of Controlled Release, 2004
- Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugatesAdvanced Drug Delivery Reviews, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Macromolecular MRI Contrast Agents with Small Dendrimers: Pharmacokinetic Differences between Sizes and CoresBioconjugate Chemistry, 2003
- Nanoparticle Technology for Drug Delivery Across the Blood-Brain BarrierDrug Development and Industrial Pharmacy, 2002
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987
- Nonlinear assessment of nitrofurantoin bioavailability in rabbitsJournal of Pharmacokinetics and Biopharmaceutics, 1983
- The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid componentsLife Sciences, 1980